State Associations and DQSA Coalition Send Letter to State Boards of Pharmacy and Medicine

State pharmacy associations, along with the DQSA Coalition, a broad cross-section of organizations representing varied healthcare providers, sent a letter to all state Boards of Pharmacy and Medicine, expressing concern regarding the Food & Drug Administration’s (FDA) implementation of the Drug Quality & Security Act (DQSA) without following Congressional intent. The letter stressed that FDA’s actions are affecting patient access to compounded medications, and causing confusion for the states, providers, patients, and pharmacists.

“Our organizations urge the members of your Board to delay consideration of any regulatory or policy decisions on the ability of practitioners to obtain and use office-use compounded preparations until such time as the Agency issues its guidance in a manner that is consistent with Congressional intent and that preserves patient access,” according to the letter.

Read the Letter

Leave a Reply